Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, Mansy HE, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart M, Laethem JL, Flamen P. Hendlisz A, et al. Among authors: piccart m. BMC Cancer. 2013 Apr 12;13:190. doi: 10.1186/1471-2407-13-190. BMC Cancer. 2013. PMID: 23587148 Free PMC article.
[Therapeutic update on cancer of the breast].
Awada A, Leo AD, Piccart MJ. Awada A, et al. Among authors: piccart mj. Bull Cancer. 2000 Jan;87(1):49-62. Bull Cancer. 2000. PMID: 10673632 Free article. Review. French. No abstract available.
An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.
Awada A, Biganzoli L, Cufer T, Beex L, Lohrisch C, Batter V, Hamilton A, Nooij M, Piccart M. Awada A, et al. Among authors: piccart m. Eur J Cancer. 2002 Apr;38(6):773-8. doi: 10.1016/s0959-8049(01)00427-0. Eur J Cancer. 2002. PMID: 11937310 Clinical Trial.
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions.
Ferreira Filho AF, Di Leo A, Paesmans M, Beauduin M, Vindevoghel A, Michel J, Focan C, Awada A, Cardoso F, Dolci S, Bartholomeus S, Piccart MJ. Ferreira Filho AF, et al. Among authors: piccart mj. Ann Oncol. 2002 Mar;13(3):416-21. doi: 10.1093/annonc/mdf051. Ann Oncol. 2002. PMID: 11996473 Free article. Clinical Trial.
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy JY, Paesmans M, Isola J, Piccart MJ. Di Leo A, et al. Among authors: piccart mj. Clin Cancer Res. 2002 May;8(5):1107-16. Clin Cancer Res. 2002. PMID: 12006526 Clinical Trial.
625 results